Julie Jordan
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ Donna M. Cochener, as attorney-in-fact for Julie Jordan
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Julie Jordan:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neurogene Inc. | Chief Medical Officer | Common Stock | 12,472 | $273,051 | $21.89 | 26 Mar 2026 | Direct |
| Homology Medicines, Inc. | Chief Medical Officer | Common Stock | 7,496 | $4,243 | $0.5660 | 03 Aug 2023 | Direct |
| Neurogene Inc. | Chief Medical Officer | Employee Stock Option (Right to buy) | 50,300 | 26 Mar 2025 | Direct | ||
| Neurogene Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 29,600 | 20 Feb 2026 | Direct | ||
| Homology Medicines, Inc. | Chief Medical Officer | Restricted Stock Units | 0 | $1.15 | 03 Aug 2023 | Direct |
Insider Reports Filed by Julie Jordan
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NGNE | Neurogene Inc. | 26 Mar 2026 | 1 | -$18,128 | 4 | Chief Medical Officer | 30 Mar 2026, 17:38 |
| NGNE | Neurogene Inc. | 20 Feb 2026 | 2 | $0 | 4 | Chief Medical Officer | 24 Feb 2026, 18:49 |
| NGNE | Neurogene Inc. | 26 Mar 2025 | 2 | $0 | 4 | Chief Medical Officer | 28 Mar 2025, 21:28 |
| NGNE | Neurogene Inc. | 16 Jan 2024 | 1 | $0 | 4 | Chief Medical Officer | 18 Jan 2024, 18:48 |
| NGNE | Neurogene Inc. | 16 Jan 2024 | 0 | $0 | 3 | Chief Medical Officer | 18 Jan 2024, 18:45 |
| QTTB | Homology Medicines, Inc. | 03 Aug 2023 | 9 | -$2,576 | 4 | Chief Medical Officer | 07 Aug 2023, 21:39 |
| QTTB | Homology Medicines, Inc. | 02 Aug 2023 | 3 | -$130 | 4 | Chief Medical Officer | 04 Aug 2023, 16:08 |
| QTTB | Homology Medicines, Inc. | 07 Mar 2023 | 0 | $0 | 3 | Chief Medical Officer | 16 Mar 2023, 17:03 |